Charlton- Pharm for Parkinsons Flashcards
(34 cards)
Main symptoms of Parkinson’s
pill rolling tremor
hypokinesia- cogwheel rigidity
muscular rigidity- shuffling gait
Major site affected in Parkinson’s
nigrostriatal pathway signified by the presence of lewy bodies
Other systems affected in Parkinson’s
- Locus ceruleus
- hypothalamus
- dorsal motor nucleus of vagus
- sympathetic ganglia
- adrenal medulla
Parksinon’s main biochemical pathway damaged
- depletion of nigrostriatal dopamine
- increased acetylcholinergic activity
Minor biochemical changes in Parkinson’s
- depletion of tyrosine hydroxylase
- depletion of melanin pigments
- decreased norepinephrine and serotonin
Goal of Drugs for PD
- increase dopamine
- stimulate DA receptors
- enhance of DA release/availability
- muscarinic cholinergic antagonists
- block adenosine receptors
2 L-dopa drugs
LARODOPA
DOPAR
- most effective bc it crossess BBB
side effects of L -dopa
hallucinations
orthostatic hypotension
confusion
L-dopa Adjuvants
LAAD/AADC inhibitors
COMT inhinbitors
MAO inhibitors
L-Aromatic acmino acid decarboxylase (LAAD)
Carbidopa
Benserazide
CARBIDOPA
BENSERAZIDE
- allow more L-dopa to reach the brain
- decreases the dosage of L-dopa needed
Carbidopa/levodopa dosage forms
sinemet
atamet
PARCOPA
COMT inhibitors
Entacapone (COMTAN)
Tolcapone (TASMAR)
MAO inhitiors
Selegiline/deprenyl (ELDEPRYL)
ZELEPAR
ENSAM
LADOSTIGIL
TRANYLCYPROMINE
PHENELZINE
DA receptor agonists
Ropinirole (REQUIP)
Pramipexole (MIRAPEX)
Bromocryptine (PARLODEL)
Pergolide (PERMAX)
Lisuride
Carbergoline
Apomorphine (APOKYN)
Enhancer dopamine release
Amandadine (STMMETREL)
Muscarinic cholinergic antagonists
Benztropine mesylate (COGENTIN) Trihexyphenidyl (ARTANE) Diphenhydramine HCl (BENADRYL)
Muscarinic cholinergic antagonists
Benztropine mesylate (COGENTIN) Trihexyphenidyl (ARTANE) Diphenhydramine HCl (BENADRYL) Procyclidine (KEMADRIN) Biperiden (Akineton) Ethopromazine (PARSIDOL, PARSITAN) not in USA
anticholinergic agents main function
decrease tremor
Alzheimer’s disease main pathophysiology
- loss of basal nucleus of Meynert
- loss of septal Ach neurons
Risk factors for AD
- chromosome 21, 14 and 1
treatment goal of AD
- augment cholinergic functions
best treatment for AD
inhibitors of acetylcholinesterase
Inhibitors of Acetylcholine esterase
Donepezil (ARICEPT)
Rivastigmine (Excelon)
Galantamine (REMINYL, RAZADYNE)
Tacrine (COGNEX)
Physostigmine
Memantine (NAMENDA)